TACE联合射频消融术后肝癌残留或复发的影像学研究进展
Progress of Imaging Assessment in Residual or Recurrent Lesions after Transcatheter Arterial Chemoembolization Combined with Radiofrequency Ablation
朱楠 1张甜甜 2周春泽3
作者信息
- 1. 安徽省蚌埠市中医医院影像科(安徽蚌埠 233000)
- 2. 安徽省五河县人民医院药剂科(安徽蚌埠 233300)
- 3. 中国科学技术大学附属第一医院介入放射科(安徽合肥 231000)
- 折叠
摘要
肝动脉化疗栓塞术(transcatheter arterial chemoembolization,TACE)联合射频消融术(radiofrequency ablation,RFA)是中晚期肝癌的有效治疗手段,但病灶术后残留或复发是影响联合治疗疗效的重要因素.影像学检查在肝癌患者随访中扮演重要角色,其中包括数字减影血管造影(DSA)、肝脏超声检查、CT、磁共振(MRI)以及正电子发射断层扫描(positron emission tomography,PET)等,本文将对TACE联合RFA术后残留或复发的影像学技术应用情况作一综述.
Abstract
Transcatheter arterial chemoembolization(TACE)combined with radiofrequency ablation(RFA)is an effective treatment for advanced liver cancer,but postoperative residual or recurrence of lesions is an important factor affecting the efficacy of combined therapy.lmaging examinations play an important role in the follow-up of liver cancer patients,including digital silhouette angiography(DSA),liver ultrasonography,CT,magnetic resonance imaging(MRI),and positron emission tomography(PET),etc.Combined with the application of imaging techniques in residual or recurrent lesions after RFA,this review was made.
关键词
肝癌/化疗栓塞/射频消融/残留或复发/影像学Key words
Hepatocellular Carcinoma/Chemoembolization/Radiofrequency Ablation/Active Lesion/Imaging引用本文复制引用
基金项目
安徽省重点研究与开发计划项目(202004j07020013)
安徽省科研编制计划项目(2022AH040192)
安徽省自然科学基金项目(2108085MH302)
出版年
2024
NETL
NSTL
维普
万方数据